A phase I study of ruxolitinib in children with relapsed/refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group Phase I Consortium study (ADVL1011).
Sarah K. Tasian
No relevant relationships to disclose
Mignon L. Loh
No relevant relationships to disclose
Karen R. Rabin
No relevant relationships to disclose
Patrick Andrew Brown
No relevant relationships to disclose
Charlotte H. Ahern
No relevant relationships to disclose
Brenda Weigel
No relevant relationships to disclose
Susan Blaney
No relevant relationships to disclose